Alexander Santini compensation by year
LEXICON PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Salary | $313,572 | $393,830 | $399,719 | $409,459 | $315,075 |
| Bonus | $162,000 | $93,313 | $102,501 | $166,768 | $0 |
| Stock awards | $77,162 | $149,743 | $248,568 | $428,766 | $233,554 |
| Option awards | $139,132 | $425,329 | $470,603 | $437,777 | $518,641 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 |
| All other | $11,051 | $11,611 | $11,828 | $12,047 | $286,765 |
| Total | $702,917 | $1,073,826 | $1,233,219 | $1,454,817 | $1,354,036 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LEXICON PHARMACEUTICALS, INC. DEF 14A filed March 19, 2021, accession 0001062822-21-000016, and prior-year filings. Open the filing on EDGAR.
How this page was built: the LEXICON PHARMACEUTICALS, INC. filed document, accession 0001062822-21-000016. Every figure is read from that document and cited to the page and table it appears in. Filed March 19, 2021.
LEXICON PHARMACEUTICALS’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Lonnel Coats | Chief Executive Officer and Director | $3,860,671 |
| Pablo Lapuerta | Former Executive Vice President and Chief Medical Officer | $1,862,885 |
| Jeffrey Wade | President and Chief Financial Officer | $1,629,502 |
| Praveen Tyle | Executive Vice President, Research and Development | $1,609,821 |
| Alexander Santini · this page | Former Executive Vice President and Chief Commercial Officer | $1,354,036 |
| Alan Main | Executive Vice President, Innovation and Chemical | $1,305,309 |
| Brian Crum | Senior Vice President and General Counsel | $1,209,201 |
| Kenneth Kassler-Taub | Senior Vice President, Regulatory and Quality | $704,569 |
The full LEXICON PHARMACEUTICALS compensation record
free company briefThis page is one person within LEXICON PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the LEXICON PHARMACEUTICALS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LEXICON PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.